Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study
Author:
Affiliation:
1. Milan Italy
2. Leipzig Germany
3. Barcelona Spain
4. Heidelberg Germany
5. Frankfurt Germany
6. Hamburg Germany
7. Nottingham UK
8. Lyon France
9. Foster City CA USA
Funder
Gilead Sciences Europe Ltd
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15901/fullpdf
Reference55 articles.
1. World Health Organization Fact sheet on hepatitis B 2019 https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
2. Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus;Delaney;Antimicrob Agents Chemother,2006
3. Tenofovir disoproxil fumarate;Kearney;Clin Pharmacokinet,2004
4. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B;Marcellin;N Engl J Med,2008
5. Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection;Buti;Dig Dis Sci,2015
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study;The Lancet Gastroenterology & Hepatology;2024-08
2. Real‐world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B;Journal of Viral Hepatitis;2024-01
3. Renal function in patients with chronic hepatitis B during antiviral therapy;Medicinski Glasnik;2023-11-06
4. Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis;Expert Review of Gastroenterology & Hepatology;2023-05-09
5. Assessment of Adherence to Clinical Guidelines in Patients with Chronic Hepatitis B;Viruses;2022-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3